AC Immune SA
ACIUAC Immune SA is a Swiss biopharmaceutical company focused on developing therapies for neurodegenerative and age-related diseases, including Alzheimer's and Parkinson's. It specializes in innovative platforms such as antibody and vaccine development to target misfolded proteins associated with these conditions.
Company News
AC Immune reported Q3 2025 financial results, highlighting a strategic refocus on high-value neurodegenerative disease assets, reducing workforce by 30%, and maintaining cash resources until Q3 2027. The company is progressing multiple clinical-stage immunotherapy and small molecule programs targeting neurodegenerative diseases.
Biogen, Eli Lilly's, Prothena and AC Immune are included in this Analyst Blog.
The FDA has granted a Fast Track Designation to its Alzheimer's disease vaccine candidate.
Use these tips to trade penny stocks when you have limited capital The post Trading Penny Stocks With Limited Capital: 3 Tops Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health. Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) surged 76.3% to $3.2450 after the company announced initial dose escalation data demonstrated anti-tumor activity of BDTX-1535 in non-small cell lu...
